Metraipolis › archive › dc_d7ece9ea61fa

DPYD Genotyping of Patients with Fluoropyrimidine Treatment: Results of Protocol Implementation and Outcomes of Patients Carrying Unusual DPYD Variants — Europe PMC PMID:42510779

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42510779
DOI: 10.3390/genes17070741
License (as archived): solo-consultazione
Archived: 2026-10-31T08:38:56.305Z
SHA-256 of the archived text: 84c76708e6364107cfaf951c7fc6d3ecbd9b68c394ab8b7b40e7375bcf115295
Stable URL of this page: https://metraipolis.com/documento/dc_d7ece9ea61fa

How to cite

DPYD Genotyping of Patients with Fluoropyrimidine Treatment: Results of Protocol Implementation and Outcomes of Patients Carrying Unusual DPYD Variants — Europe PMC PMID:42510779 — Europe PMC (en), https://europepmc.org/article/MED/42510779 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7ece9ea61fa (Metraipolis archive dc_d7ece9ea61fa, sha256 84c76708e6364107cfaf951c7fc6d3ecbd9b68c394ab8b7b40e7375bcf115295)

BibTeX

@misc{dcd7ece9ea61fa,
  title = {DPYD Genotyping of Patients with Fluoropyrimidine Treatment: Results of Protocol Implementation and Outcomes of Patients Carrying Unusual DPYD Variants — Europe PMC PMID:42510779},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42510779},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7ece9ea61fa; sha256 84c76708e6364107cfaf951c7fc6d3ecbd9b68c394ab8b7b40e7375bcf115295},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42510779. Agents can read the archived copy with the MCP tool read_document.